Lichen Planus: Symptoms, Causes, and Treatment

You've been told your skin condition is "just stress" or "just cosmetic." You've tried every cream, changed your diet, and still the purple patches or white streaks persist. Or maybe you've been diagnosed with lichen planus, but no one has explained why it keeps coming back or what's actually happening beneath the surface.

Key Takeaways

• Lichen planus is an immune-mediated condition where T cells attack skin and mucous membranes.
• It affects skin, mouth, scalp, nails, and genitals with distinct patterns in each location.
• Triggers include medications, hepatitis C infection, stress, and genetic susceptibility.
• Lichen planus vs lichen sclerosus: lichen planus affects mucous membranes; lichen sclerosus rarely does.
• Oral and genital forms carry a small long-term risk of malignant transformation.
• Treatment focuses on immune suppression, not remission, as the condition often resolves spontaneously.
• Persistent or treatment-resistant cases warrant investigation for systemic associations like autoimmune disease.

What Lichen Planus Actually Is and Where It Starts

Lichen planus is a chronic inflammatory condition driven by a T cell-mediated immune attack on basal keratinocytes, the cells that form the foundation of your skin and mucous membranes. The immune system, for reasons not fully understood, identifies these cells as foreign and launches a targeted assault. The result is inflammation, cell death, and the characteristic lesions that define the condition.

On the skin, lichen planus typically presents as flat-topped, purple or violet papules, often with fine white lines on the surface called Wickham striae. These lesions favor the wrists, ankles, lower back, and inner forearms. In the mouth, it appears as white, lacy patches on the inner cheeks, tongue, or gums, sometimes accompanied by painful erosions. On the scalp (lichen planus scalp), it can cause scarring hair loss. On the nails, it leads to thinning, ridging, or permanent nail loss. In the genital area, it produces painful erosions, scarring, and in severe cases, structural changes that affect function.

The condition has multiple subtypes:

• Cutaneous lichen planus is the classic skin form with purple papules and Wickham striae.
• Oral lichen planus is one of the most common, affecting up to 2% of the population.
• Lichen planopilaris targets hair follicles on the scalp, leading to permanent alopecia.
• Erosive lichen planus affects mucous membranes and is the most symptomatic with highest complication risk.
• Lichen planus pigmentosus leaves dark patches on the skin, particularly in individuals with darker skin tones.

How the Immune System Drives a Lichen Planus Flare

Lichen planus is not a skin problem that happens to involve the immune system. It is an immune problem that manifests in the skin. The pathology centers on cytotoxic CD8+ T cells infiltrating the basal layer of the epidermis and triggering apoptosis (programmed cell death) of keratinocytes. This process is mediated by inflammatory cytokines, including interferon-gamma, tumor necrosis factor-alpha, and interleukins that amplify the immune response.

The condition is classified as a Th1-dominant immune response, meaning the immune system is skewed toward cell-mediated immunity rather than antibody production. This is the same immune pathway involved in other autoimmune and inflammatory conditions, which is why lichen planus is often seen alongside diseases like Hashimoto's thyroiditis, lupus, and primary biliary cholangitis.

Hepatitis C infection is one of the most well-documented systemic associations. The virus appears to trigger immune dysregulation in genetically susceptible individuals. Studies show that oral lichen planus is significantly more common in people with chronic hepatitis C, particularly in certain geographic regions. However, treating the hepatitis C infection does not always resolve the lichen planus, suggesting the immune activation becomes self-sustaining once initiated.

Stress and the hypothalamic-pituitary-adrenal (HPA) axis also play a role. Chronic stress elevates cortisol, which paradoxically can impair immune regulation and increase susceptibility to autoimmune flares. Patients frequently report worsening during periods of psychological or physical stress, and this reflects a real neuroimmune mechanism.

What Triggers a Lichen Planus Flare and Why the Same Thing Doesn't Affect Everyone

Lichen planus does not have a single cause. It has triggers that activate an underlying immune susceptibility:

• Medications: Drug-induced lichenoid reactions are triggered by beta-blockers, ACE inhibitors, NSAIDs, antimalarials, thiazide diuretics, and gold salts.
• Infections: Hepatitis C is the most studied infectious trigger, but hepatitis B and HIV have also been implicated through molecular mimicry mechanisms.
• Contact allergens: Oral lichen planus can be triggered by dental materials (particularly amalgam fillings), metals, fragrances, or preservatives.
• Genetic susceptibility: HLA-DR1 and HLA-DR6 gene variants increase susceptibility by regulating immune response.
• Microbiome and gut health: Dysbiosis and intestinal permeability may influence systemic inflammatory tone and contribute to flares.

Why the Same Condition Looks Different and Responds Differently in Different People

Lichen planus is not a monolithic disease. Two people with the same diagnosis can have entirely different presentations, severities, and treatment responses. This variation is driven by immune phenotype, genetic background, and environmental exposures.

Immune phenotype determines whether the condition is predominantly Th1-driven, with more cytotoxic T cell activity, or whether other immune pathways are involved. Some patients have a more robust inflammatory response, leading to erosive or ulcerative lesions, while others have a milder, reticular pattern. Skin type and melanin content affect both the appearance and the risk of post-inflammatory hyperpigmentation. In individuals with darker skin tones, lichen planus often leaves dark patches that persist long after the active inflammation has resolved.

Prior treatment history also shapes response. Patients who have been on long-term topical or systemic corticosteroids may develop steroid dependence or rebound flares when treatment is tapered. Those with a history of autoimmune disease may have a more chronic, relapsing course. Hormonal fluctuations can influence lichen planus, particularly in women. Some patients report worsening during menstruation, pregnancy, or menopause, suggesting that estrogen and progesterone levels modulate immune activity in this condition.

When Skin Symptoms Point to Something Systemic

Lichen planus is not always an isolated skin condition. Persistent, severe, or treatment-resistant cases warrant investigation for systemic associations. The most clinically significant include autoimmune diseases, chronic infections, and metabolic conditions.

Autoimmune thyroid disease, particularly Hashimoto's thyroiditis, is more common in patients with lichen planus than in the general population. The shared Th1 immune pathway explains this overlap. Screening with TSH, thyroid peroxidase antibodies, and thyroglobulin antibodies is reasonable in patients with lichen planus, especially if they have fatigue, weight changes, or other thyroid symptoms. Primary biliary cholangitis, an autoimmune liver disease, has been reported in association with lichen planus. Patients with unexplained elevations in alkaline phosphatase or gamma-glutamyl transferase should be evaluated further.

Oral and genital lichen planus carry a small but real risk of malignant transformation to squamous cell carcinoma. The risk is highest in erosive forms and in patients with chronic, uncontrolled inflammation. Regular monitoring and biopsy of suspicious lesions are essential.

Lichen planus vs lichen sclerosus is a common point of confusion. Both affect the genitals and cause itching, pain, and scarring. The key difference is that lichen planus frequently involves mucous membranes, including the mouth and vagina, while lichen sclerosus rarely does. Lichen sclerosus presents as thin, white, wrinkled skin, often described as having a "cigarette paper" texture, and is more likely to cause architectural changes in the genital area. Both conditions require long-term monitoring due to malignancy risk.

What Biomarkers Can Tell You When Topicals Aren't Enough

When lichen planus is persistent, severe, or associated with systemic symptoms, testing can identify underlying drivers and guide treatment. The goal is not to diagnose lichen planus (which is typically a clinical and histologic diagnosis) but to uncover systemic factors that may be perpetuating the condition.

For patients with oral lichen planus, hepatitis C screening is essential. This includes hepatitis C antibody testing and, if positive, hepatitis C RNA to confirm active infection. Even in the absence of liver symptoms, chronic hepatitis C can drive immune dysregulation. Autoimmune screening is warranted in patients with multiple autoimmune features or a family history of autoimmune disease. This includes antinuclear antibodies (ANA), rheumatoid factor, and anti-dsDNA antibodies. Thyroid function testing and thyroid antibodies are particularly relevant given the overlap with autoimmune thyroid disease.

Inflammatory markers, including high-sensitivity C-reactive protein (hs-CRP) and erythrocyte sedimentation rate (ESR), can provide a baseline measure of systemic inflammation. Elevated markers suggest a more systemic inflammatory process and may indicate the need for more aggressive treatment. Nutrient deficiencies, particularly vitamin D, vitamin B12, and ferritin, are common in chronic inflammatory conditions and can impair immune regulation and tissue repair. Correcting deficiencies may not resolve lichen planus but can support overall immune function and reduce symptom severity.

For patients with suspected drug-induced lichenoid reactions, a detailed medication history and, in some cases, discontinuation of the suspected drug under medical supervision can clarify the diagnosis.

Getting to the Root of What's Driving Your Skin

If your lichen planus keeps coming back despite doing everything right topically, Superpower's 100+ biomarker panel can show you what's happening at the immune, hormonal, and metabolic level. Chronic inflammation, autoimmune markers, nutrient deficiencies, and infectious triggers don't always show symptoms, but they show up in your blood. Managing lichen planus often starts with identifying these underlying systemic factors. Lichen planus is one of the most visible signals your biology produces. Superpower's 100+ biomarker panel helps you read that signal at a systemic level, not just treat it at the surface.